These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20496170)

  • 1. Psychosocial variables associated with colorectal cancer screening in South Australia.
    Cole SR; Zajac I; Gregory T; Mehaffey S; Roosa N; Turnbull D; Esterman A; Young GP
    Int J Behav Med; 2011 Dec; 18(4):302-9. PubMed ID: 20496170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.
    Duncan A; Turnbull D; Wilson C; Osborne JM; Cole SR; Flight I; Young GP
    BMC Public Health; 2014 Mar; 14():238. PubMed ID: 24606951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the Transtheoretical Model of Behaviour Change to describe readiness to rescreen for colorectal cancer with faecal occult blood testing.
    Duncan A; Turnbull D; Gregory T; Cole SR; Young GP; Flight I; Wilson C
    Health Promot J Austr; 2012 Aug; 23(2):122-8. PubMed ID: 23088473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer.
    Gregory TA; Wilson C; Duncan A; Turnbull D; Cole SR; Young G
    BMC Public Health; 2011 Jan; 11():38. PubMed ID: 21232156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Informed Decisions and Participation in Bowel Cancer Screening among Adults with Lower Education and Literacy.
    Smith SK; Simpson JM; Trevena LJ; McCaffery KJ
    Med Decis Making; 2014 Aug; 34(6):756-72. PubMed ID: 24421292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Educational Intervention Based on Health Belief Model and Social Support on the Rate of Participation of Individuals in Performing Fecal Occult Blood Test for Colorectal Cancer Screening.
    Gholampour Y; Jaderipour A; Khani Jeihooni A; Kashfi SM; Afzali Harsini P
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2777-2787. PubMed ID: 30360606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust.
    Chambers JA; Callander AS; Grangeret R; O'Carroll RE
    BMC Cancer; 2016 Feb; 16():96. PubMed ID: 26872450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.
    He E; Lew JB; Egger S; Banks E; Ward RL; Beral V; Canfell K
    Prev Med; 2018 Jan; 106():185-193. PubMed ID: 29109015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening knowledge, attitudes and behavioural intention among Indigenous Western Australians.
    Christou A; Thompson SC
    BMC Public Health; 2012 Jul; 12():528. PubMed ID: 22809457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to Health Care, Beliefs, and Behaviors about Colorectal Cancer Screening among Korean Americans.
    Lee SY; Lee EE
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):2021-2027. PubMed ID: 30051703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer.
    Cole SR; Young GP; Esterman A; Cadd B; Morcom J
    J Med Screen; 2003; 10(3):117-22. PubMed ID: 14561262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
    Damery S; Clifford S; Wilson S
    BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of re-participation in faecal occult blood test- based screening for colorectal cancer.
    Cole SR; Gregory T; Whibley A; Ward P; Turnbull D; Wilson C; Flight I; Esterman A; Young GP
    Asian Pac J Cancer Prev; 2012; 13(12):5989-94. PubMed ID: 23464391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.
    Heresbach D; Manfredi S; D'halluin PN; Bretagne JF; Branger B
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):427-33. PubMed ID: 16538116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.